Effect of Self-Acupressure on Peripheral Neuropathic Pain and HbA1c

Launched by YEDITEPE UNIVERSITY · May 28, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of self-applied acupressure on two important aspects for people with type 2 diabetes: pain caused by nerve damage (called peripheral neuropathic pain) and a blood test result known as HbA1c, which shows how well diabetes is being managed over time. The goal is to see if patients can learn to do acupressure on themselves to help relieve their pain and improve their blood sugar levels.

To participate, individuals must be at least 18 years old, have type 2 diabetes, and be experiencing nerve pain. They should not have any significant mental health issues or disabilities that affect their ability to learn and perform acupressure. Participants will receive training on how to do acupressure and will practice it three times a week for three months, while the other group will continue with their usual care. This study aims to provide new insights into self-care techniques that might help improve the quality of life for those living with diabetes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 18 years and over,
• • Diagnosed with type-2 diabetes,
• • Diagnosed with peripheral neuropathy,
• • DN4 score ≥ 4,
• • Not diagnosed with a psychiatric disease,
• • No hearing, visual or physical disabilities
• • Knowing how to read and write,
• • Able to communicate, no language problems,
• • Having the equipment (smartphone, computer, tablet, etc.) to watch self-acupressure videos and receive reminder text messages,
• • Patients who volunteer to participate in the study and give verbal and written consent will be included in the study.
• Exclusion Criteria:
• • Presence of lesion/scar/mass/open wound at the point where acupressure will be applied,
• • Having a non-diabetic disease that causes neuropathy,
• • Starting to use new medication to control neuropathic symptoms,
• • Changing the dose of the current drug used to control neuropathic symptoms (if it is used routinely and the dose will not be changed, it can be included in the study),
• • Adding a new oral antidiabetic drug to your current treatment,
• • Not using insulin normally and starting a new insulin treatment,
• • The need for a new insulin dose adjustment in insulin users (individuals who currently use insulin and whose dose will not be changed can be included in the study),
• • Failure to comply with planned initiatives,
• • Using psychiatric medication,
• • Having a visual or hearing impairment,
• • Having a mental disability or perception problem,
• • Already doing self-acupressure,
• • Not being willing to participate in the study is a criterion that will exclude individuals from the study.

Trial Officials